Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Saved in:
Bibliographic Details
Title: Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.
Authors: Beavogui AH, Doumbia S, Kieh M, Leigh B, Sow S, Lhomme E, Ben-Farhat S, Dubois Cauwelaert N, Roy C, Diouf W, Idrissa S, Diarra S, Millimouno NP, Diallo FA, Kamara M, Pratt D, Dicko I, Kennedy SB, Espérou H, Choi EM, Kpetigo AD, D'Ortenzio E, Diallo A, Lancrey-Javal S, Hamzé B, Schwimmer C, Wiedemann A, Ayouba A, Peeters M, Lane HC, Higgs E, Watson-Jones D, Yazdanpanah Y, Greenwood B, Richert L, Levy Y
Corporate Authors: PREVAC study Team
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.64898/2026.05.29.26354050